Have a personal or library account? Click to login
A Critique of Helsinki Criteria for Using Lung Fiber Levels to Determine Causation in Mesothelioma Cases Cover

A Critique of Helsinki Criteria for Using Lung Fiber Levels to Determine Causation in Mesothelioma Cases

Open Access
|Jul 2021

References

  1. 1 Srebro SH, Roggli VL, Samsa GP. Malignant mesothelioma associated with low pulmonary tissue asbestos burdens: A light and scanning electron microscopic analysis of 18 cases. Mod Pathol. 1995, Aug; 8: 614621.
  2. 2 Landrigan P. Collegium Ramazzini. Comments on the 2014 Helsinki Consensus Report on Asbestos. Ann Glob Health. 2016; 82: 217220. DOI: 10.1016/j.aogh.2016.01.018
  3. 3 Baur X, Woitowitz H, Budnik L, et al. Asbestos, asbestosis, and cancer: The Helsinki criteria for diagnosis and attribution. Critical need for revision of the 2014 update. American Journal of Industrial Medicine. 2017; 60: 411421. DOI: 10.1002/ajim.22709
  4. 4 Wolff H, Vehmas T, Oksa P, et al. Response by the organizers of the Helsinki criteria updates 2014: Criteria for asbestos-related diseases need periodic updates. Scand J Work Environ Health. 2016; 42: 9596. DOI: 10.5271/sjweh.3536
  5. 5 Pavlisko EN, Liu B, Green C, et al. Malignant Diffuse Mesothelioma in Women: A Study of 354 Cases. The American Journal of Surgical Pathology. 2020; 44: 293304. DOI: 10.1097/PAS.0000000000001418
  6. 6 Roggli V, Greenberg M, Pratt P. Pathology of asbestos-associated diseases. 1st ed. Boston, MA: Little, Brown & Co; 1992. DOI: 10.1007/0-387-21819-X_1
  7. 7 Roggli V. Asbestos content of lung tissue in asbestos associated diseases: A study of 110 cases. British Journal of Industrial Medicine. 1986; 43: 1828. DOI: 10.1136/oem.43.1.18
  8. 8 Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Asbestos. 2001.
  9. 9 Goldberg M, Luce D. The health impact of nonoccupational exposure to asbestos: What do we know? Eur J Cancer Prev. 2012; 18: 489503. DOI: 10.1097/CEJ.0b013e32832f9bee
  10. 10 U.S. Environmental Protection Agency. Title 40 — protection of environment, Chapter 1, Subchapter C. Air programs, Part 61. National emission standards for hazardous air pollutants: asbestos, beryllium, and mercury. 38 FR 8820–8850. 1973.
  11. 11 U.S. Environmental Protection Agency. National Emission Standards for Hazardous Air Pollutants (NESHAP): proposed standards for asbestos, beryllium, mercury. 1971.
  12. 12 Egilman D. Fiber Types, Asbestos Potency, and Environmental Causation: A Peer Review of Published Work and Legal and Regulatory Scientific Testimony. Int J Occup Environ Health. 2009; 15: 202228. DOI: 10.1179/oeh.2009.15.2.202
  13. 13 Roggli V. Electron Microprobe Analysis of Ferruginous Bodies Obtained from Autopsy Cases. 1995. https://repository.library.brown.edu/studio/item/bdr:1095276/. Accessed June 23, 2020.
  14. 14 Albin M, Pooley F, Strömberg U, et al. Retention patterns of asbestos fibres in lung tissue among asbestos cement workers. Occup Environ Med. 1994; 51: 205211. DOI: 10.1136/oem.51.3.205
  15. 15 Newman L, Gottschall E. Asbestosis. In: Albert R (ed.), Clinical Respiratory Medicine. Philadelphia, PA: Mosby, Inc.; 2008. DOI: 10.1016/B978-032304825-5.10065-0
  16. 16 Lajoie P, Dion C, Drouin L, et al. Asbestos Fibres in Indoor and Outdoor Air – The Situation in Quebec. In: Sub-Committee on Exposure Measurement (ed.), Institut national de santé publique du Québec (INSPQ), 2003. https://www.inspq.qc.ca/pdf/publications/342-AsbestosIndoorOutdoorAir.pdf. Accessed June 23, 2020.
  17. 17 United States Geological Survey. Mineral Commodity Summaries 2020. In: U.S. Department of the Interior BoM (ed.), 2020. https://pubs.usgs.gov/periodicals/mcs2020/mcs2020.pdf. Accessed June 23, 2020.
  18. 18 Roggli V. Deposition in Boyle vs. A.W. Chesterton Company et al. in the Iowa District Court for Polk County. 2009; 130132. https://repository.library.brown.edu/studio/item/bdr:1097892/. Accessed June 23, 2020.
  19. 19 Sayers R, Dreessen W. Asbestosis. Am J Public Health Nations Health. 1939; 29: 205214. DOI: 10.2105/AJPH.29.3.205
  20. 20 Dodson R, Atkinson M, Levin J. Asbestos Fiber Length as Related to Potential Pathogenicity: A Critical Review. American Journal of Industrial Medicine. 2003; 44: 291297. DOI: 10.1002/ajim.10263
  21. 21 Hume L, Rimstidt D. Letter: The biodurability of chrysotile asbestos. American Mineralogist. 1992; 77: 11251128.
  22. 22 Jaurand M, Gaudichet A, Halpern S, et al. In vitro biodegradation of chrysotile fibers by alveolar macrophages and mesothelial cells in culture: Comparison with a pH effect. British J Ind Medicine. 1984; 41: 389395. DOI: 10.1136/oem.41.3.389
  23. 23 Churg A, Wright J. Persistence of natural mineral fibers in human lungs: An overview. Environ Health Perspect. 1994; 102: 229233. DOI: 10.1289/ehp.94102s5229
  24. 24 Roggli VL, Sanders LL. Asbestos content of lung tissue and carcinoma of the lung: A clinicopathologic correlation and mineral fiber analysis of 234 cases. Ann Occup Hyg. 2000; 44: 109117. DOI: 10.1016/S0003-4878(99)00067-8
  25. 25 Warnock M, Prescott B, Kuwahara T. Correlation of Asbestos Bodies and Fibers in Lungs of Subjects With and Without Asbestosis. Scan Electron Microsc. 1982; Part 2: 845857.
  26. 26 Aust A, Cook P, Dodson R. Morphological And Chemical Mechanisms Of Elongated Mineral Particle Toxicities. Journal of Toxicology and Environmental Health, Part B. 2011; 14: 4075. DOI: 10.1080/10937404.2011.556046
  27. 27 Smith A, Wright C. Chrysotile asbestos is the main cause of pleural mesothelioma. Am J Ind Med. 1996; 30: 252266. DOI: 10.1002/(SICI)1097-0274(199609)30:3<;252::AID-AJIM2>3.0.CO;2-0
  28. 28 Churg A, Warnock M. Asbestos Fibers in the General Population. American Review of Respiratory Disease. 1980; 122: 669678. DOI: 10.1164/arrd.1980.122.5.669
  29. 29 Anttila S, Karjalainen A, Taikina-aho O, et al. Lung cancer in the lower lobe is associated with pulmonary asbestos fiber count and fiber size. Environ Health Perspect. 1993; 101: 166170. DOI: 10.1289/ehp.93101166
  30. 30 Gylseth B, Randi B. Topographic and Size Distribution of Asbestos Bodies in Exposed Human Lungs. Scandinavian Journal of Work, Environment & Health. 1981; 7: 190195. DOI: 10.5271/sjweh.3111
  31. 31 Finnish Institute of Occupational Health. Asbestos, Asbestosis and Cancer: Helsinki Criteria for Diagnosis and Attribution 2014. 2014.
  32. 32 U.S. Environmental Protection Agency. AHERA Training Workshop for NESHAP Inspectors – Student Manual. In: Office of Air Quality and Standards (ed.), Washington, DC 20460. 1990. https://nepis.epa.gov/Exe/ZyPDF.cgi/91024QIF.PDF?Dockey=91024QIF.PDF. Accessed June 23, 2020.
  33. 33 Upton A, Barrett J, Becklake M, et al. Asbestos in Public and Commercial Buildings: A Literature Review and Synthesis of Current Knowledge. In: Health Effects Institute (HEI) (ed.), 1991. https://www.healtheffects.org/system/files/SR_1991_Ch1-5_0.pdf. Accessed June 23, 2020.
  34. 34 Rigler MW. Expert Report: Regarding Alan R. Lohman Lung Tissue Analysis For Asbestos Burden Performed by Victor Roggli, MD. MAS Laboratory, 2010. https://repository.library.brown.edu/studio/item/bdr:1097460/. Accessed June 23, 2020.
  35. 35 Pooley F, Clark N. Fiber dimensions and aspect ratio of crocidolite, chrysotile and amosite particles detected in lung tissue specimens. Annals New York Academy of Sciences. 1979; 330: 711716. DOI: 10.1111/j.1749-6632.1979.tb18775.x
  36. 36 Dodson R, Hammar S. Asbestos: Risk Assessment, Epidemiology, and Health Effects. Boca Raton, FL: CRC Press – Taylor & Francis Group; 2011.
  37. 37 Roggli V, Gibbs A, Attanoos R, et al. Pathology of asbestosis- An update of the diagnostic criteria: Report of the asbestosis committee of the college of american pathologists and pulmonary pathology society. Arch Pathol Lab Med. 2010; 134: 462480. DOI: 10.5858/134.3.462
  38. 38 Langer A, Nolan R, Addison J. Distinguishing between amphibole asbestos fibers and elongate leavage fragments of the non-asbestos analogues. Mechanisms in Fibre Carcinogenesis. 1991. DOI: 10.1007/978-1-4684-1363-2_22
  39. 39 Egilman D. Health Effects of Censored Elongated Mineral Particles: A Critical Review. In: Brisson M (ed.), Detection Limits in Air Quality and Environmental Measurements. West Conshohocken, PA: ASTM International. 2019; 192239. DOI: 10.1520/STP161820180080
  40. 40 Sullivan M, Corn C, Dodson R. Comparative Efficiency of Nuclepore Filters of Various Pore Sizes as Used in Digestion Studies of Tissue. Environmental Research. 1987; 43: 97103. DOI: 10.1016/S0013-9351(87)80061-0
  41. 41 Wylie A. Discriminating Amphibole Cleavage Fragments from Asbestos: Rationaled and Methodology. Exposure Assessment and Control Asbestos/Other Fibrous Material. 1988.
  42. 42 International Organization for Standardization. ISO 14966: Ambient air — Determination of numerical concentration of inorganic fibrous particles — Scanning electron microscopy method. 2019.
  43. 43 Chesson J, Leczynski B, Berner T, et al. Guidelines for conducting the AHERA (Asbestos Hazard Emergency Response Act) TEM (Transmission Electron Microscopy) clearance test to determine completion of an asbestos abatement project. Final report. Report no. PB-90-171778/XAB United States NTIS, PC A03/MF A01 GRA English, 1989.; Washington, DC, USA: Chesson Consulting.
  44. 44 Roggli V. Deposition in Stepanek vs. Brenntag North America et al. in the Circuit Court of Cook County, Illinois. 2020; 4849. https://repository.library.brown.edu/studio/item/bdr:1095278/. Accessed June 23, 2020.
  45. 45 Virta RL. The Phase Relationship of Talc and Amphiboles in a Fibrous Talc Sample. 1985.
  46. 46 Roggli V, Carney J, Sporn T, et al. Response to letter regarding “Talc and mesothelioma: Mineral fiber analysis of 65 cases with clinicopathological correlation.” Ultrastructural Pathology. 2020. DOI: 10.1080/01913123.2020.1737286
  47. 47 Gordon R. Cosmetic Talcum Powder as a Causative Factor in the Development of Diseases of the Pleura. Diseases of Pleura. 2019. DOI: 10.5772/intechopen.88194
  48. 48 Langer A, Nolan R. Chrysotile: Its Occurrence And Properties As Variables Controlling Biological Effects. British Occupational Hygiene Society. 1993; 33: 427451.
  49. 49 Pooley F. Electron microscope characteristics of inhaled chrysotile asbestos fibre. Brit J industr Med. 1972; 29: 146153. DOI: 10.1136/oem.29.2.146
  50. 50 Roggli V. Deposition in Ropp vs. American Honda Motor Company et al. in the Circuit Court of Caroline County, Maryland. 2015; 6263. https://repository.library.brown.edu/studio/item/bdr:1105308/. Accessed June 23, 2020.
  51. 51 Feder I, Tischoff I, Theile A, et al. The asbestos fibre burden in human lungs: New insights into the chrysotile debate. Eur Respir J. 2017; 49: 1602534. DOI: 10.1183/13993003.02534-2016
  52. 52 Roggli V. Deposition in Ropp vs. American Honda Motor Company et al. in the Circuit Court of Caroline County, Maryland. 2015; 7678. https://repository.library.brown.edu/studio/item/bdr:1105308/. Accessed June 23, 2020.
  53. 53 Oury T, Roggli V, Sporn T. Pathology of asbestos-associated diseases. Third Edition ed. New York, NY: Springer; 2014. DOI: 10.1007/978-3-642-41193-9
  54. 54 Gylseth B, Churg A, Davis J, et al. Analysis of asbestos fibers and asbestos bodies in tissue samples from human lung. An international interlaboratory trial. Scand J Work Environ Health. 1985; 11: 107110. DOI: 10.5271/sjweh.2246
  55. 55 Case W, Abraham J, Meeker G, et al. Applying Definitions of “Asbestos” to Environmental and “Low-Dose” Exposure Levels and Health Effects, Particularly Malignant Mesothelioma. Journal of Toxicology and Environmental Health. 2011; Part B: 339. DOI: 10.1080/10937404.2011.556045
  56. 56 Churg A. The Distribution of Amosite Asbestos in the Periphery of the Normal Human Lung. British Journal of Industrial Medicine. 1990; 47: 677681. DOI: 10.1136/oem.47.10.677
  57. 57 Roggli V, Carney J, Sporn T, et al. Talc and mesothelioma: Mineral fiber analysis of 65 cases with clinicopathological correlation. Ultrastructural Pathology. 2020; 44: 211218. DOI: 10.1080/01913123.2020.1737286
  58. 58 Tran T, Steffen J, Clancy K, et al. Talc, Asbestos, and Epidemiology: Corporate Influence and Scientific Incognizance. Epidemiology. 2019; 30: 783788. DOI: 10.1097/EDE.0000000000001091
  59. 59 National Toxicology Program. Draft Report on Carcinogens: Background Document for Talc – Asbestiform and Non-Asbestiform. Meeting of the NTP Board of Scientific Counselors – Report on Carcinogens Subcommittee. 2000. https://repository.library.brown.edu/studio/item/bdr:841468/. Accessed June 23, 2020.
  60. 60 Steffen JE, Tran T, Yimam M, et al. Serous Ovarian Cancer Caused by Exposure to Asbestos and Fibrous Talc in Cosmetic Talc Powders—A Case Series. Journal of Occupational and Environmental Medicine. 2020; 62: e65e77. DOI: 10.1097/JOM.0000000000001800
  61. 61 Roggli V. Deposition in Stepanek vs. Brenntag North America et al. in the Circuit Court of Cook County, Illinois. 2020; 9394. https://repository.library.brown.edu/studio/item/bdr:1095278/. Accessed June 23, 2020.
  62. 62 Roggli VL. Deposition in DiBenedetto vs. Noble Drilling Company et. al. in the Civil District Court of the Parish of New Orleans page 268–271. 2009. https://repository.library.brown.edu/studio/item/bdr:1095279/. Accessed June 23, 2020.
  63. 63 McEwen G. Letter to Dr. C.W. Jameson, NTP RE: Call for Public Comments on 21 Substances. Mixtures and Exposure Circumstances Proposed for Listing in the Report on Carcinogens, Twelfth Edition (69 Federal Register 28940): Cosmetic Talc. 2004.
  64. 64 Tossavainen A. Asbestos, asbestosis, and cancer: The Helsinki criteria for diagnosis and attribution. Scand J Work Environ Health. 1997; 23: 311316. DOI: 10.5271/sjweh.226
  65. 65 Roggli V, Vollmer R, Butner K, et al. Tremolite and Mesothelioma. Ann Occup Hyg. 2002; 46: 447453.
  66. 66 Ashton W. Memo to Leebaw, J. Re: Johnson’s Baby Powder Use, JNJ 000312709. 1991. https://repository.library.brown.edu/studio/item/bdr:841456/. Accessed June 23, 2020.
  67. 67 Nam K, Gracey DR. Pulmonary talcosis from cosmetic talcum powder. JAMA. 1972; 221: 492493. DOI: 10.1001/jama.1972.03200180034009
  68. 68 Roggli V. Deposition in Stepanek vs. Brenntag North America et al. in the Circuit Court of Cook County, Illinois. 2020; 88. https://repository.library.brown.edu/studio/item/bdr:1095278/. Accessed June 23, 2020.
DOI: https://doi.org/10.5334/aogh.3135 | Journal eISSN: 2214-9996
Language: English
Published on: Jul 29, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2021 Triet Tran, David Egilman, Mark Rigler, Theresa Emory, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.